ACTH increment post total bilateral adrenalectomy for Cushing’s disease: a consistent biosignature for predicting Nelson’s syndrome
Authors:
- Liza DasLDLiza Das
- Anil BhansaliABAnil Bhansali
- Rosario PivonelloRosario Pivonello
- Pinaki DuttaPDPinaki Dutta
- Sanjay Kumar BhadadaSBSanjay Kumar Bhadada
- Chirag Kamal AhujaCAChirag Kamal Ahuja
- Ravimohan MavuduruRMRavimohan Mavuduru
- Santosh KumarSKSantosh Kumar
- Arunanshu BeheraABArunanshu Behera
- Uma Nahar SaikiaUSUma Nahar Saikia
- Sivashanmugam DhandapaniSDSivashanmugam Dhandapani
- Rama WaliaRWRama Walia
- 25 May 2020
- journal article
- research article
- Published by Springer Nature in Pituitary
- Vol. 23 (5) , 488-497
Abstract
Purpose Nelson’s syndrome (NS) is regarded as an aggressive complication of total bilateral adrenalectomy (TBA) for Cushing’s disease (CD). This challenge may be addressed by using clinical criteria to guide frequency of neuroimaging to enable timely management of NS and also avoid unnecessary frequent imaging. Methods All patients (n = 43) with CD subjected to TBA over 35 years at a tertiary care centre were included. NS was defined as a newly appearing or expanding (> 2 mm) pituitary adenoma with or without ACTH levels exceeding 500 pg/ml. Pre-and post-TBA parameters like clinical symptomatology, cortisol, ACTH and radiology were analysed for the prediction of NS. Results NS developed in 39.5% (n = 17) patients with a median follow-up of 7 years. Half of them had new appearance, while rest had an expansion of pre-existing pituitary tumour. Majority (90%) had ACTH above 500 pg/ml. On Cox proportional hazards analysis, frequent discriminatory features of protein catabolism (≥ 4) (HR 1.15, CI 0.18, 7.06), proximal myopathy (HR 8.82, CI 1.12, 69.58) and annual ACTH increment of 113 pg/ml (HR 12.56, CI 1.88, 88.76) predicted NS. First post-operative year ACTH indices predicting NS included ACTH rise of 116 pg/ml and absolute ACTH of 142 pg/ml (sensitivity, specificity exceeding 90%). Annual ACTH increment exceeding 113 pg/ml, ≥ 4 discriminatory features and uncontrolled hypertension had the best overall prediction. Conclusion Patients who developed NS had higher rebound rise of ACTH following TBA and a more severe disease phenotype at baseline. Consistent ACTH increment can be used as a marker for predicting the development of NS.Keywords
This publication has 32 references indexed in Scilit:
- The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2008
- Nelson's SyndromeArchives of Endocrinology and Metabolism, 2007
- Bilateral laparoscopic adrenalectomy for corticotrophin–dependent Cushing's syndrome: a review of the Mayo Clinic experienceClinical Endocrinology, 2007
- Multicenter evaluation of a rapid electrochemiluminescent adrenocorticotropic hormone (ACTH) immunoassayClinica Chimica Acta, 2007
- Corticotroph Tumor Progression after Adrenalectomy in Cushing’s Disease: A Reappraisal of Nelson’s SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2007
- The Nelson's syndrome... revisitedPituitary, 2004
- Activation of virilizing adrenal rest tissues by excessive ACTH productionThe American Journal of Medicine, 1982
- THE DOSE‐RESPONSE RELATIONSHIP OF ACTH AND CORTISOL IN CUSHING'S DISEASEClinical Endocrinology, 1980
- Adrenocorticotropin-Dependent Virilizing Paraovarian Tumors in Nelson's Syndrome*The Journal of Clinical Endocrinology & Metabolism, 1979
- ACTH-Producing Tumor of the Pituitary GlandNew England Journal of Medicine, 1958